Voya Investment Management LLC Outlook Therapeutics, Inc. Transaction History

Voya Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.22 - $0.66 $6,697 - $20,093	30,445 New	30,445 $11,000
Q2 2023 Aug 14, 2023	BUY	$1.02 - $1.89 $4,920 - $9,117	4,824 Added 7.94%	65,561 $114,000
Q1 2023 May 15, 2023	BUY	$1.0 - $1.35 $13,744 - $18,554	13,744 Added 29.25%	60,737 $66,000
Q2 2022 Aug 15, 2022	BUY	$0.91 - $2.01 $7,665 - $16,932	8,424 Added 21.84%	46,993 $48,000
Q1 2022 May 16, 2022	BUY	$1.22 - $2.03 $6,916 - $11,508	5,669 Added 17.23%	38,569 $69,000
Q4 2021 Feb 14, 2022	SELL	$1.27 - $2.23 $3,962 - $6,957	-3,120 Reduced 8.66%	32,900 $45,000
Q2 2021 Aug 16, 2021	BUY	$1.78 - $2.76 $64,115 - $99,415	36,020 New	36,020 $90,000

31.5K

Ticker OTLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,144,992
Market Cap $1.17B
Description
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.